Caribou cuts pipeline and workforce to focus on lead CAR-T programmes
Caribou is scaling back its operations, halting multiple programmes, and cutting staff to focus on two cancer programmes.
Themes
AstraZeneca enters $200m AI cancer pact with Tempus and Pathos
Eli Lilly and BigHat Biosciences ink AI antibody discovery deal
3 reasons why biotechs preparing for launch need a compliant content foundation
AD/PD 2025: DHTs can detect disease progression in patients with early Parkinson’s
Google-backed Isomorphic Labs raises $600m to advance AI drug discovery
EU Health Data Space strikes a chord in EU harmonisation plans
Mastering compliance and copyright in healthcare and MedComms
